Wang Dongjuan, Liu Shan, Yang Jing, et al. Consensus for Newborn Screening of Inherited Metabolic Disorders during the Coronavirus Disease 2019 Epidemic. [J]. 27(10):47-49(2021)
DOI:
Wang Dongjuan, Liu Shan, Yang Jing, et al. Consensus for Newborn Screening of Inherited Metabolic Disorders during the Coronavirus Disease 2019 Epidemic. [J]. 27(10):47-49(2021) DOI: 10.13407/j.cnki.jpp.1672-108X.2021.10.014.
Consensus for Newborn Screening of Inherited Metabolic Disorders during the Coronavirus Disease 2019 Epidemic
The 2019 novel coronavirus (2019-nCoV) infection that emerged at the end of 2019 has been occurring in many places and countries all over the world
and has not yet been fully controlled
with infections in children and even newborns having been reported. Approximately 15 million newborns are born each year in China
and there is a potential risk of newborn screening for inherited metabolic disorders. Based on the current status
some experts from the newborn screening center of Children’s Hospital of Chongqing Medical University and Clinical Laboratory Center of National Health Commission formulate the contingency suggestion for screening
diagnosis
treatment and follow-up of newborn screening of inherited metabolic disorders during the coronavirus disease 2019 (COVID-2019) epidemic.